FDA Inspection
Xellia Pharmaceuticals ApSXellia Pharmaceuticals ApS – FDA Inspection, May 8, 2018
Record Details
This FDA Inspection record concerns Xellia Pharmaceuticals ApS, with an inspection on May 8, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a6084c75-ea0b-484b-889e-1677b96c612f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1051572
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Xellia Pharmaceuticals ApS
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 28, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 25, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 15, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 6, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 16, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Xellia Pharmaceuticals ApS
- FDA Inspection 1244910 - 2021-10-28
- FDA Inspection 1123814 - 2019-10-25
- FDA Inspection 975111 - 2016-03-15
- FDA Inspection 880296 - 2014-05-06
- FDA Inspection 806442 - 2012-10-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.